2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
«
←
2
3
4
Date
Headline
Feb 8, 2016
CEL-SCI To Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference
Feb 3, 2016
CEL-SCI to Present at 18th Annual BIO CEO & Investor Conference
Feb 1, 2016
CEL-SCI Reports Monthly Patient Enrollment in January for Its Phase 3 Head and Neck Cancer Trial
Jan 25, 2016
CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine
Jan 14, 2016
CEL-SCI Corporation to Present at the Noble Financial Capital Markets’ 12th Annual Investor Conference
Jan 8, 2016
CEL-SCI Corporation Summarizes Significant Accomplishments in 2015 and Positive Momentum for 2016
Jan 5, 2016
CEL-SCI Reports Record Year for Patient Enrollment with 75% Increase in Its Global Phase 3 Head and Neck Cancer Trial